Skip to content

Effectiveness and safety of fluoroscopy-guided acupuncture for subacromial impingement syndrome

Effectiveness and safety of fluoroscopy-guided acupuncture for subacromial impingement syndrome; a randomized, patient-assessor blind, parallel clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002751
Enrollment
54
Registered
2018-03-23
Start date
2018-01-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Participants who met the inclusion criteria are randomised to one of two parallel groups. Participants in the experimental group receive acupuncture twice to the subacromial space us
s condition). Performs acupuncture through fluoroscopy in Fluoroscopy(FLO) mode. Acupuncture treatment with proportional measurements of the control group - Acupuncture : We use sterile acupuncture (

Sponsors

Wonkwang University, Gwangju Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged 25 to 65 years old, with no limitation of shouler motion of range 2) Those who have the shoulder pain lasting more than 2 months from the onset and the pain is worse when sleeping sideways or lifting the arm over the head, with positive on Neer or Hawkins test, with more than 50 mm on pain of visual analogue scale(VAS), who can be diagnosed as subacromial impingement syndrome by excluding fracture, dislocation, degenerative arthropathy, os acromiale, subacromial spur, and calcific tendinitis in plain radiography. 3) Those who have minimal help with the nature of the pain and are able to communicate sufficiently with the researcher and write a questionnaire. 4) Those who have pledged not to receive treatment other than the prescribed treatment within the period of study. 5) Agreed with written informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) History of shoulder surgery, fracture, dislocation trauma 2) Patients with disorders of the cervical spine or other upper extremity that has a significant impact on the shoulder 3) Patients who received injection treatment on shoulder within 6 months 4) Patients with fracture, dislocation, degenerative arthropathy(GH joint, AC joint) os acromiale, subacromial spur ,and calcific tendinitis of the shoulder in plain radiography 5) Patients with positive findings in physical examination(drop arm test, empty can test) for exclusion of rotator cuff tear 6) Patients with positive findings in physical examination(Yergason test) for exclusion of biceps tendinitis 7) Patients who diagnosed as a frozen shoulder (adhesive capsulitis) in range of motion test 8) Patients with clinically meaningful medical conditions (pacemaker insertion, significant arrhythmia on electrocardiography, etc.) under the judgment of the researcher 9) Patients with concomitant disorders contraindicated to Acetaminophen or hypersensitivity to Acetaminophen(Acetaminophen is relief medication in this study) 9) Pregnant or breastfeeding female patients, patients with positive findings in the urine pregnancy test before random assignment, patients who are unable or unwilling to use appropriate contraceptive methods (hormonal contraceptives, condoms, intrauterine devices, etc.) to avoid pregnancy throughout the entire trial period 10) Patients with mental disorders who can not follow the this clinical trial protocol 11) Patients who were considered as unsuitable for participation by the researcher

Design outcomes

Primary

MeasureTime frame
100mm Visual analogue scale(VAS) of shoulder pain

Secondary

MeasureTime frame
test for impingement syndrome (Neer test and Hawkins test);function of shoulder joint (Modified Constant Murley Score scale, Shoulder Pain And Disability Index);Patient Satisfaction Evaluation;Accuracy rate;Vital signs (Blood pressure, pulse, body temperature);Adverse events

Countries

Korea, Republic of

Contacts

Public ContactJihye Seo

Wonkwang University, Gwangju Medical Center

herbabaa@gmail.com+82-62-670-6790

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 25, 2026